Catherine Offord

Catherine Offord

After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science writer. She has worked in various guises at The Scientist, starting as an intern in early 2016 before becoming a correspondent. As associate editor, she now writes articles for the online and print publications, and edits the magazine’s Notebook, Careers, and Bio Business sections.

Articles by Catherine Offord
Physician Behind Surgisphere Scandal Switches Medical Licenses
Physician Behind Surgisphere Scandal Switches Medical Licenses
Catherine Offord | Oct 23, 2020
Sapan Desai has inactivated his license in Illinois, where multiple malpractice lawsuits against him are pending, and obtained a new one in Ohio.
SARS-CoV-2 Disables Key Components of Human Cells’ Defense System
SARS-CoV-2 Disables Key Components of Human Cells’ Defense System
Catherine Offord | Oct 22, 2020
Researchers detail how viral proteins interact with host RNA to disrupt the cell’s ability to fight back against infection.
Study Points to Novel Role for Microglia in Down Syndrome
Study Points to Novel Role for Microglia in Down Syndrome
Catherine Offord | Oct 6, 2020
Overactive immune cells identified in a mouse model and in postmortem human brain tissue may offer a potential therapeutic target for cognitive delays associated with the condition, researchers report.
Timeline: When Bad Research Changes Public Health Strategy
Timeline: When Bad Research Changes Public Health Strategy
Catherine Offord | Oct 1, 2020
Illinois-based Surgisphere Corporation had a brief moment in the limelight this year following its infamous study of hydroxychloroquine. But the impact of the company’s deception reverberated across world.
The Surgisphere Scandal: What Went Wrong?
The Surgisphere Scandal: What Went Wrong?
Catherine Offord | Oct 1, 2020
The high-profile retractions of two COVID-19 studies stunned the scientific community earlier this year and prompted calls for reviews of how science is conducted, published, and acted upon. The warning signs had been there all along.
<em>The Lancet&nbsp;</em>Alters Editorial Practices After Surgisphere Scandal
The Lancet Alters Editorial Practices After Surgisphere Scandal
Catherine Offord | Sep 22, 2020
The changes, which affect the declarations authors have to sign and the peer-review process, have received a mixed response from the scientific community.
Bird Flu Viruses Can Remain Infectious for Months in US Wetlands
Bird Flu Viruses Can Remain Infectious for Months in US Wetlands
Catherine Offord | Sep 10, 2020
Lab and field experiments indicate that aquatic environments could act as reservoirs for the pathogens, which typically do not represent a direct risk to humans.
Steroid Drugs Are an Effective Treatment for Severe COVID-19: WHO
Steroid Drugs Are an Effective Treatment for Severe COVID-19: WHO
Catherine Offord | Sep 3, 2020
A meta-analysis of seven randomized controlled trials concludes that dexamethasone and other corticosteroids reduce 28-day mortality in seriously ill patients.
Infectious Disease Researcher Steve Meshnick Dies
Infectious Disease Researcher Steve Meshnick Dies
Catherine Offord | Aug 13, 2020
A leading scientist on the mechanisms of action of antimalarial medications, the University of North Carolina professor made contributions to research and mentoring all around the world.
Gilead Urged to Explore Remdesivir Relative as COVID-19 Drug
Gilead Urged to Explore Remdesivir Relative as COVID-19 Drug
Catherine Offord | Aug 11, 2020
Citizen advocates push the pharmaceutical company to examine a compound that has been used to treat certain coronavirus infections in cats.